Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Utomo, Elaine ^a   Groen, Jan ^a   Blok, Bertil F M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BACLOFEN; BOTULINUM TOXIN A; LIDOCAINE; PLACEBO; MUSCLE RELAXANT AGENT;

ADULT; ADVERSE EVENT; AGE; BALLOON DILATATION; BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER OBSTRUCTION; COMORBIDITY; CONGENITAL MALFORMATION; DISEASE DURATION; ELECTROMYOGRAPHY; HUMAN; INCONTINENCE; MAXIMAL URETHRAL PRESSURE; MAXIMUM DETRUSOR PRESSURE; META ANALYSIS; MICTURITION; MULTIPLE SCLEROSIS; NEUROGENIC BLADDER; OUTCOME ASSESSMENT; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; SPHINCTERIC STENT PROSTHESIS; SPHINCTEROTOMY; SPINAL CORD INJURY; SURGICAL APPROACH; SYSTEMATIC REVIEW; TREATMENT DURATION; URINE RETENTION; URODYNAMICS; UROGENITAL SYSTEM PARAMETERS; ATAXIA; COMPLICATION; CONGENITAL DISORDER; FEMALE; MALE; STENT; URETHRA; URINARY BLADDER NECK OBSTRUCTION; URINE;

ADULT; ATAXIA; BOTULINUM TOXINS, TYPE A; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL CORD INJURIES; STENTS; URETHRA; URINARY BLADDER NECK OBSTRUCTION; URINARY BLADDER, NEUROGENIC; URINE;

EID: 84938128947     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004927.pub4     Document Type: Review

References (90)

1. Chancellor MB, Bennett C, Simoneau AR, Finocchiaro MV, Kline C, Bennett JK, et al.Sphincteric stent versus external sphincterotomy in spinal cord injured men: prospective randomized multicenter trial. Journal of Urology 1999;161(6):1893-8. [PUBMED: 10332461].
2. Cui X-G, Qu C-Y, Xu D-F, Ren J-Z, Kong L-L, Lin H-Y. Botulinum toxin injection into urethral external sphincter combined with oral baclofen in treatment of patients with detrusor-external sphincter dyssynergia after spinal cord injury. Academic Journal of Second Military Medical University 2007;28(8):875-7.
3. de Sèze M, Petit H, Gallien P, de Sèze MP, Joseph PA, Mazaux JM, et al.Botulinum A toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. European Urology 2002;42(1):56-62. [PUBMED: 12121731].
4. Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Archives of Physical Medicine and Rehabilitation 1990;71(1):24-6. [PUBMED: 2297305].
5. Gallien P, Reymann JM, Amarenco G, Nicolas B, de Sèze M, Bellissant E. Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. Journal of Neurology, Neurosurgery, and Psychiatry 2005;76(12):1670-6. [PUBMED: 16291892].
6. Chancellor MB, Rivas DA, Abdill CK, Karasick S, Ehrlich SM, Staas WE. Prospective comparison of external sphincter balloon dilatation and prosthesis placement with external sphincterotomy in spinal cord injured men. Archives of Physical Medicine and Rehabilitation 1994;75:297-305. [PUBMED: 8129583].
7. Dunn MD, Portis AJ, Kahn SA Yan Y, Shalhav AL, Elbahnasy AM, et al.Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. Journal of Endourology 2000;14(2):195-202. [PUBMED: 10772515].
8. Herschorn S, Gajewski J, Ethans K, Corcos J, Carlson K, Bailly G, et al.Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence - a randomized double-blind trial (Abstract number 33). Neurourology and Urodynamics 2009;28(7):608-9.
9. Herschorn S, Gajewski J, Ethans K, Corcos J, Carlson K, Bailly G, et al.Botulinum toxin A in patients with neurogenic detrusor overactivity: preliminary results from a Canadian multicentre randomized trial (Abstract number: Poster# 50). Neurourology and Urodynamics 2009;28(2):138-9.
10. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991;29(1):48-64. [PUBMED: 2023770].
11. Mehta S, Hill D, Foley N, Hsieh J, Ethans K, Potter P, et al.A meta-analysis of botulinum toxin sphincteric injections in the treatment of incomplete voiding after spinal cord injury. Archives of Physical Medicine and Rehabilitation 2012;93(4):597-603. [PUBMED: 22365478].
12. Meythaler JM Guin-Renfroe S Brunner RC Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001;32(9):2099-109. [PUBMED: 11546903].
13. Naumann M, So Y, Argoff CE, Childers MK, Dykstra DD, Gronseth GS, et al.Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70(19):1707-14. [PUBMED: 18458231].
14. Schurch B, de Seze M, Denys P, Chartier-Kastler E, Ismael S, Haab F, et al.Botulinum toxin A (Botox) in neurogenic urinary incontinence: results from a multi-centre randomised, controlled trial (Abstract). Neurourology and Urodynamics. 2004; Vol. 23, issue 5/6:609-10.
15. Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, et al.Subgroup analysis to determine impact of patient demographics on urodynamic response to focal administration of botulinum toxin A (Abstract). Neurourology and Urodynamics 2005;24(5/6):545-6.
16. Schurch B, Denys P, Kozma CM, Reese PR, Slaton T, Barron RL. Botulinum toxin a improves the quality of life of patients with neurogenic urinary incontinence. European Urology 2007;52(3):850-8. [PUBMED: 17467889].
17. Steers WD, Meythaler JM, Haworth C, Herrell D, Park TS. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. Journal of Urology 1992;148(6):1849-55. [PUBMED: 1433619].
18. Thavaseelan JT, Burns-Cox N, Jordan K, Trewhella J. Efficacy of botulinum toxin type A (BOTOX) in the management of the neurogenic bladder: a prospective, randomised, double blind, dose comparative trial - interim overview of results (Abstract). BJU International 2005;95(Suppl 1):4-5.
19. Abdul-Rahman A, Ismail S, Hamid R, Shah J. A 20-year follow-up of the mesh wallstent in the treatment of detrusor external sphincter dyssynergia in patients with spinal cord injury. BJU International 2010;106(10):1510-3. [PUBMED: 20500511].
20. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al.The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society. Neurourology and Urodynamics 2002;21(2):167-78. [DOI: 10.1002/nau.10052].
21. Angaut-Petit D, Molgó J, Comella JX, Faille L, Tabti N. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience 1990;37(3):799-808. [PUBMED: 1701041].
22. Araki I, Matsui M, Ozawa K, Takeda M, Kuno S. Relationship of bladder dysfunction to lesion site in multiple sclerosis. Journal of Urology 2003;169(4):1384-7. [PUBMED: 12629367].
23. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe L, Mebust WK, et al.The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. Journal of Urology 1992;148(5):1549-57. [PUBMED: 1279218].
24. Blaivas JG, Sinha HP, Zayed AA, Labib KB. Detrusor-external sphincter dyssynergia: a detailed electromyographic study. Journal of Urology 1981;125(4):545-8. [PUBMED: 7218457].
25. Blok BF, de Weerd H, Holstege G. The pontine micturition center projects to sacral cord GABA immunoreactive neurons in the cat. Neuroscience Letters 1997;233(2-3):109-12. [PUBMED: 9350844].
26. Blok BF. Central pathways controlling micturition and urinary continence. Urology 2002;59(5 Suppl 1):13-7. [PUBMED: 12007517].
27. Boger A, Bhadra N, Gustafson KJ. Bladder voiding by combined high frequency electrical pudendal nerve block and sacral root stimulation. Neurourology and Urodynamics 2008;27(5):435-9. [PUBMED: 18041769].
28. Brooks R. EuroQol: the current state of play. Health Policy 1996;37(1):53-72. [PUBMED: 10158943].
29. Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ. Bladder management after spinal cord injury in the United States 1972 to 2005. Journal of Urology 2010;184(1):213-7. [PUBMED: 20478597].
30. Chancellor MB, Hirsch IH, Kiilholma P, Staas WE. Technique of external sphincter balloon dilatation. Urology 1992;40(4):308-10. [PUBMED: 1413347].
31. Chancellor MB, Karasick S, Strup S, Abdill CK, Hirsch IH, Staas WE. Transurethral balloon dilation of the external urinary sphincter: effectiveness in spinal cord-injured men with detrusor-external urethral sphincter dyssynergia. Radiology 1993;187(2):557-60. [PUBMED: 8475307].
32. Chancellor MB, Rivas DA, Abdill CK, Karasick S, Ehrlich SM, Staas WE. Prospective comparison of external sphincter balloon dilatation and prosthesis placement with external sphincterotomy in spinal cord injured men. Archives of Physical Medicine and Rehabilation 1994;75(3):297-305. [PUBMED: 8129583].
33. Chancellor MB, Gajewski J, Ackman CF, Appell RA, Bennett J, Binard J, et al.Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. Journal of Urology 1999;161(5):1545-50. [PUBMED: 10210393].
34. Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, et al.Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. European Urology 2001;39(1):107-13. [PUBMED: 11173948].
35. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldfish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. Journal of Urology 1988;139(5):919-22. [PUBMED: 3361663].
36. Institute of Clinical Effectiveness and Health Policy. Early Review Organizing Software (EROS). Buenos Aires, Argentina: Institute of Clinical Effectiveness and Health Policy, 2013. [: http://www.eros-systematic-review.org/].
37. Feifer A, Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourology and Urodynamics 2008;27(6):475-9. [PUBMED: 18551568].
38. Ganesan V, Borzyskowski M. Characteristics and course of urinary tract dysfunction after acute transverse myelitis in childhood. Developmental Medicine and Child Neurology 2001;43(7):473-5. [PUBMED: 11463178].
39. Gaunt RA, Prochazka A. Transcutaneously coupled, high-frequency electrical stimulation of the pudendal nerve blocks external urethral sphincter contractions. Neurorehabilitation and Neural Repair 2009;23(6):615-26. [PUBMED: 19109445].
40. Gross RA, Johnston KC. Levels of evidence: Taking Neurology to the next level. Neurology 2009;72(1):8-10. [PUBMED: 19122025].
41. Hagen S, Sinclair L, Cross S. Washout policies in long-term indwelling urinary catheterisation in adults. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD004012.pub4].
42. Hamid R, Arya M, Wood S, Patel HRH, Shah PJR. The use of the Memokath stent in the treatment of detrusor sphincter dyssynergia in spinal cord injury patients: a single-center seven-year experience. European Urology 2003;43:539-43. [PUBMED: 12706000].
43. Hansen RB, Biering-Sorensen F, Kristensen JK. Bladder emptying over a period of 10-45 years after a traumatic spinal cord injury. Spinal Cord 2004;42:631-7. [PUBMED: 15326470].
44. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org 2011.
45. Hoffman RM, MacDonald R, Wilt T. Laser prostatectomy for benign prostatic obstruction. Cochrane Database of Systematic Reviews 2000, Issue 1. [DOI: 10.1002/14651858.CD001987.pub2].
46. Hoffman RM, Monga M, Elliott SP, MacDonald R, Langsjoen J, Tacklind J, et al.Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD004135.pub3].
47. Jamison J, Maguire S, McCann J. Catheter policies for management of long term voiding problems in adults with neurogenic bladder disorders. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD004375.pub2].
48. Kalisvaart JF, Katsumi HK, Ronningen LD, Hovey RM. Bladder cancer in spinal cord injury patients. Spinal Cord 2010;48(3):257-61. [PUBMED: 19752870].
49. Kalita J, Shah S, Kapoor R, Misra UK. Bladder dysfunction in acute transverse myelitis: magnetic resonance imaging and neurophysiological and urodynamic correlations. Journal of Neurology, Neurosurgery, and Psychiatry 2002;73(2):154-9. [PUBMED: 12122174].
50. Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One 2010;5(3):e9810. [DOI: 10.1371/journal.pone.0009810; PUBMED: 20339557].
51. Ko HY, Kim KT. Treatment of external urethral sphincter hypertonicity by pudendal nerve block using phenol solution in patients with spinal cord injury. Spinal Cord 1997;35(10):690-3. [PUBMED: 9347599].
52. Liu CW, Attar KH, Gall A, Shah J, Craggs M. The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK. Spinal Cord 2010;48(4):319-24. [PUBMED: 19841636].
53. Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJC. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD005429.pub2; PUBMED: 22258963].
54. McFarlane JP, Foley SJ, Shah PJ. Balloon dilatation of the external urethral sphincter in the treatment of detrusor-sphincter dyssynergia. Spinal Cord 1997;35(2):96-8. [PUBMED: 9044516].
55. Milroy EJ, Chapple CR, Cooper JE, Eldin A, Wallsten H, Seddon AM, et al.A new treatment for urethral strictures. Lancet 1988;1(8600):1424-7. [PUBMED: 2898583].
56. Miyazato M, Sasatomi K, Hiragata S, Sugaya K, Chancellor MB, de Groat WC, et al.Suppression of detrusor-sphincter dyssynergia by GABA-receptor activation in the lumbosacral spinal cord in spinal cord-injured rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2008;295(1):R336-42. [PUBMED: 18495826].
57. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al.CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869. [DOI: 10.1136/bmj.c869].
58. Moore KN, Fader M, Getliffe K. Long-term bladder management by intermittent catheterisation in adults and children. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD006008.pub2].
59. Nabi G, Cody JD, Dublin N, McClinton S, N'Dow JMO, Neal DE, et al.Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD003306].
60. Ord J, Lunn D, Reynard J. Bladder management and risk of bladder stone formation in spinal cord injured patients. Journal of Urology 2003;170(5):1734-7. [PUBMED: 14532765].
61. Pan D, Troy A, Rogerson J, Bolton D, Brown D, Lawrentschuk N. Long-term outcomes of external sphincterotomy in a spinal injured population. Journal of Urology 2009;181(2):705-9. [PUBMED: 19091341].
62. Pannek J, Stöhrer M, Blok B, Castro-Diaz D, Del Popolo G, Kramer G, et al.Guidelines on Neurogenic Lower Urinary Tract Dysfunction. EAU Guidelines, edition presented at the 25th EAU Annual Congress, Barcelona. Arnhem, the Netherlands: EAU Guidelines Office, 2011.
63. Perkash I. Modified approach to sphincterotomy in spinal cord injury patients. Indications, technique and results in 32 patients. Paraplegia 1976;13(4):247-60. [PUBMED: 1264480].
64. Perkash I. Use of contact laser crystal tip firing Nd:YAG to relieve urinary outflow obstruction in male neurogenic bladder patients. Journal of Clinical Laser Medicine & Surgery 1998;16(1):33-8. [PUBMED: 9728128].
65. New York: Thomson Reuters. Reference Manager Professional Edition. 12. New York: Thomson Reuters, 2012.
66. Reynard JM, Vass J, Sullivan ME, Mamas M. Sphincterotomy and the treatment of detrusor-sphincter dyssynergia: current status, future prospects. Spinal Cord 2003;41(1):1-11. [PUBMED: 12494314].
67. Rivas DA, Chancellor MB, Staas WE Jr, Gomella LG. Contact neodymium: yttrium-aluminium-garnet laser ablation of the external sphincter in spinal cord injured men with detrusor sphincter dyssynergia. Urology 1995;45(6):1028-31. [PUBMED: 7771003].
68. Ross JC, Gibbon NO, Damanski M. Division of the external urethral sphincter in the treatment of the paraplegic bladder: a preliminary report on a new procedure.. Paraplegia 1987;25(3):185-95. [DOI: 10.1038/sc.1987.32; PUBMED: 3601426].
69. Sahai A, Khan M, Fowler CJ, Dasgupta P. Botulinum toxin for the treatment of lower urinary tract symptoms: a review. Neurourology and Urodynamics 2005;24(1):2-12. [PUBMED: 15578628].
70. Satoh Y, Sakurai T, Ikoma F. A treatment of detrusor-sphincter dyssynergia: pudendal nerve block by phenolglycerin under the guide of direct nerve stimulation. Der Urologe A 1979;18(5):284-8. [PUBMED: 494454].
71. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. Journal of Urology 1996;155(3):1023-9. [PUBMED: 8583552].
72. Shaw PJ, Milroy EJ, Timoney AG, el Din A, Mitchell N. Permanent external striated sphincter stents in patients with spinal injuries. British Journal of Urology 1990;66(3):297-302. [PUBMED: 2207546].
73. Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Quality of Life Research 1994;3(5):291-306. [DOI: 10.1007/BF00451721; PUBMED: 7841963].
74. Simon O, Yelnik AP. Managing spasticity with drugs. European Journal of Physical and Rehabilitation Medicine 2010;46(3):401-10. [PUBMED: 20927006].
75. Soni BM, Vaidyanatham S, Krishnan KR. Use of Memokath, a second generation urethral stent for relief of urinary retention in male spinal cord injured patients. Paraplegia 1994;32(7):480-8. [PUBMED: 7970850].
76. Stöhrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. European Urology 2009;56(1):81-8. [PUBMED: 19403235].
77. Tai C, Roppolo JR, de Groat WC. Block of external urethral sphincter contraction by high frequency electrical stimulation of pudendal nerve. Journal of Urology 2004;172(5 Pt 1):2069-72. [PUBMED: 15540791].
78. Tai C, Roppolo JR, de Groat WC. Response of external urethral sphincter to high frequency biphasic electrical stimulation of pudendal nerve. Journal of Urology 2005;174(2):782-6. [PUBMED: 16006976].
79. Tsai SJ, Lew HL, Date E, Bih LI. Treatment of detrusor-sphincter dyssynergia by pudendal nerve block in patients with spinal cord injury. Archives of Physical Medicine and Rehabilitation 2002;83(5):714-7. [PUBMED: 11994813].
80. Ukkonen M, Elovaara I, Dastidar P, Tammela TL. Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system. Acta Neurologica Scandinavica 2004;109(2):100-5. [PUBMED: 14705971].
81. van Gool JD, Dik P, de Jong TP. Bladder-sphincter dysfunction in myelomeningocele. European Journal of Pediatrics 2001;160(7):414-20. [PUBMED: 11475578].
82. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992;30(6):473-83. [PUBMED: 1593914].
83. Weld KJ, Graney MJ, Dmochowski RR. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury. Urology 2000;56(4):565-8. [PUBMED: 11018603].
84. Westgren N, Levi R. Quality of life and traumatic spinal cord injury.. Archives of Physical Medicine and Rehabilitation 1998;79(11):1433-9. [PUBMED: 9821906].
85. Williamson PR, Altman DG, Blazeby JM, Clarke M, Gargon E. The COMET (Core Outcome Measures in Effectiveness Trials) initiative. Trials 2011;12(Suppl 1):A70. [DOI: 10.1186/1745-6215-12-S1-A70].
86. Wong SSW, Aboumarzouk OM, Narahari R, O'Riordan A, Pickard R. Simple urethral dilatation, endoscopic urethrotomy, and urethroplasty for urethral stricture disease in adult men. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD006934.pub3].
87. Wyndaele JJ, Kovindha A, Madersbacher H, Radziszweski P, Ruffion A, Schurch B, et al.Neurologic urinary and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A editor(s). Incontinence. 4th Edition. Health Publication Ltd, 2009:793-960.
88. Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. American Journal of Obstetrics and Gynecology 2003;189(1):98-101. [PUBMED: 12861145].
89. Yalla SV, Blunt KJ, Fam BA, Constantinople NL, Gittes RF. Detrusor-urethral sphincter dyssynergia. Journal of Urology 1977;118(6):1026-9. [PUBMED: 926242].
90. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67(6):361-70. [PUBMED: 6880820].